Merck & Co., Inc. Profile Avatar - Palmy Investing

Merck & Co., Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immuno…
Drug Manufacturers - General
US, Kenilworth [HQ]

News

Theses · Events · Sentiments
Sentiments
24-10-31 6.60%

Merck & Co posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster cancer treatment Keytruda, but the …

24-10-31 6.20%

Merck reported third-quarter revenue and adjusted earnings that topped expectations. The company saw strong sales from its top-selling cancer drug …

24-10-31 0.00%

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Third-Quarter 2024 Financial Results.

24-10-24 39.80%

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck's KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers.